Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Olschewski, H; Behr, J; Bremer, H; Claussen, M; Douschan, P; Halank, M; Held, M; Hoeper, MM; Holt, S; Klose, H; Krüger, S; Lange, TJ; Reichenberger, F; Skowasch, D; Ulrich, S; Wilkens, H; Seeger, W.
Pulmonary hypertension due to chronic lung disease: Recommendations of the Cologne Consensus Conference 2016].
Dtsch Med Wochenschr. 2016; 141(S 01):S57-S61
Doi: 10.1055/s-0042-114528
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Olschewski Horst
- Co-Autor*innen der Med Uni Graz
- Douschan Philipp
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The 2015 European Guidelines on Pulmonary Hypertension did not cover only pulmonary arterial hypertension (PAH) but also some aspects of pulmonary hypertension (PH) associated with chronic lung disease. The European Guidelines point out that the drugs currently used to treat patients with PAH (prostanoids, endothelin receptor antagonists, phosphodiesterase-5 inhibitors, sGC stimulators) have not been sufficiently investigated in other forms of PH. Therefore, the European Guidelines do not recommend the use of these drugs in patients with chronic lung disease and PH. This recommendation, however, is not always in agreement with medical ethics as physicians feel sometimes inclined to treat other form of PH which may affect quality of life and survival of these patients in a similar manner. To this end, it is crucial to consider the severity of both PH and the underlying lung disease. In June 2016, a Consensus Conference organized by the PH working groups of the German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Pediatric Cardiology (DGPK) was held in Cologne, Germany, to discuss open and controversial issues surrounding the practical implementation of the European Guidelines. Several working groups were initiated, one of which was dedicated to the diagnosis and treatment of PH in patients with chronic lung disease. The recommendations of this working group are summarized in the present paper. © Georg Thieme Verlag KG Stuttgart · New York.
- Find related publications in this database (using NLM MeSH Indexing)
- Cardiology - standards
- Germany -
- Humans -
- Hypertension, Pulmonary - diagnosis
- Hypertension, Pulmonary - etiology
- Hypertension, Pulmonary - therapy
- Lung Injury - complications
- Lung Injury - diagnosis
- Lung Injury - therapy
- Practice Guidelines as Topic -
- Pulmonary Medicine - standards
- Find related publications in this database (Keywords)
- PH-Lung
- PH-ILD
- PH-CPFE
- PH-COPD
- Atypical IPAH